baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy data from the australian rheumatology association database基线并存病的人口基数的风湿性关节炎患者接受生物治疗澳大利亚风湿病学协会的数据的数据库.pdfVIP

Hindawi Publishing Corporation International Journal of Rheumatology Volume 2009, Article ID 861481, 8 pages doi:10.1155/2009/861481 Clinical Study Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database Andrew M. Briggs,1, 2 Lyn March,3, 4 Marissa Lassere,5, 6 Christopher Reid,7, 8 Lyndall Henderson,4 Bridie Murphy,1, 7 Rosemarie van den Haak,6 Adam Rischin,1 Margaret Staples,1, 7 and Rachelle Buchbinder1, 7 1Monash Department of Clinical Epidemiology, Cabrini Hospital, Malvern, Victoria, Australia 2 School of Physiotherapy and Curtin Health and Innovation Research Institute, Curtin University of Technology, Perth, WA, Australia 3Institute of Bone and Joint Health, University of Sydney, NSW, Australia 4Department of Rheumatology, Royal North Shore Hospital, St Leonards, NSW, Australia 5Faculty of Medicine, University of New South Wales, NSW, Australia 6Department of Rheumatology, St George Hospital, Kogarah, NSW, Australia 7Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia 8 Centre for Clinical Research Excellence in Therapeutics, Monash University, Mebourne, Victoria, Australia Correspondence should be addressed to Rachelle Buchbinder, rachelle.buchbinder@.au Received 29 April 2009; Accepted 13 July 2009 Recommended by Eric Matteson Aims . To describe the baseline characteristics of an Australian population-based cohort of rheumatoid arthritis (RA) patients commencing biological therapy. Methods. Descriptive analysis from the Australian Rheumatology Association Database (ARAD). Results. Up to October 2006, there were 681 RA patients taking biologics enrolled in ARAD. Basel